MedPage Today on MSNOpinion
Spotting Trends in Patients' Tests
Statistics, and the standard deviation of our tests, mean that if you order a complete metabolic profile, a lipid panel, a ...
Pre-clinical data supports ECRIs' broad-spectrum attack on the IgE axis, distinct from conventional anti-IgE therapies, ...
Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the benefits of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, commonly referred to as INTERCEPT ...
Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of ...
Magnesium is an essential mineral, which performs more than 300 biochemical reactions in the body! We require magnesium to build muscle strength and achieve relaxation, while it also helps maintain ...
Nick Benz-Bushling never imagined that managing his son’s mental health care would turn into a real-life horror story. After years of struggles, 16-year-old Johnathan attempted suicide in February.
REDSTONE ARSENAL, Ala. (Sept. 29, 2025) – For more than six decades, the U.S. Army Combat Capabilities Development Command Aviation & Missile Center has spearheaded the next generation of U.S. Army ...
MANILA, Philippines — The Social Security System (SSS) officially launched the MySSS Card that has a dual function––an official ID and a debit card. SSS President and CEO Robert Joseph De Claro said ...
AI tools also played a crucial role in precision targeting during Operation Sindoor, Lt Gen Sahni said The Indian Army used artificial intelligence (AI) tools in a ...
Rhapsido is the first FDA-approved BTKi for CSU, targeting patients unresponsive to H1 antihistamines. REMIX trials showed Rhapsido's superiority over placebo in reducing CSU symptoms by Week 12.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results